Drug Discovery for Schizophrenia
eBook - PDF

Drug Discovery for Schizophrenia

  1. 289 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Drug Discovery for Schizophrenia

About this book

Since the pioneering pharmacotherapy for treatment of schizophrenia in the 1950s by antipsychotics, only a few major innovations have been made, pointing to a general stagnation in the field of pharmacology of schizophrenia. Drug Discovery for Schizophrenia covers new insights in the field of schizophrenia with an aim to advance the understanding of scientists and clinicians in this area and to fuel drug discovery. The book outlines a change in the way schizophrenia is treated by moving away from focusing only on treating symptoms in patients. Innovative drugs emerge from deeper comprehension of the pathological processes that emerge earlier in life, hence, providing strategies for preventative therapy to alter the course of this mental disorder. Amongst other current topics, the book covers new findings in genetics and epigenetics, progress in animal models for schizophrenia and the usage of induced pluripotent stem cells. The combination of these important areas benefit psychiatric neuroscience, filling the gaps in the knowledge of neurobiology of schizophrenia and providing novel perspectives for future drug development.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Drug Discovery for Schizophrenia by Tatiana Lipina, John Roder in PDF and/or ePUB format, as well as other popular books in Physical Sciences & Pharmacology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Royal Society of Chemistry
Year
2015
eBook ISBN
9781782622499
Edition
1
Topic
Physical Sciences
Subtopic
Pharmacology

Table of contents

  1. cover
  2. Preface
  3. Contents
  4. Chapter 1 The Genetics of Schizophrenia
  5. Chapter 2 The Impact of Epigenetics in Schizophrenia Research
  6. Chapter 3 Developmental Neuroimmune Mechanisms in Schizophreia
  7. Chapter 4 The Self-medication Hypothesis in Schizophrenia: What Have We Learned from Animal Models
  8. Chapter 5 Modelling Schizophrenia: Strategies for Identifying Improved Platforms for Drug Discovery
  9. Chapter 6 Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia
  10. Chapter 7 Disrupted-in-Schizophrenia-1 (DISC1) Interactome and Schizophrenia
  11. Chapter 8 GSK3 Networks in Schizophrenia
  12. Chapter 9 Protein Interactions with Dopamine Receptors as Potential New Drug Targets for Treating Schizophrenia
  13. Chapter 10 Optogenetic and Chemogenetic Tools for Drug Discovery in Schizophrenia
  14. Subject Index